The European Journal of Health Economics

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
A method for cross-sector priority setting
The European Journal of Health Economics - Tập 5 - Trang 317-323 - 2004
Tugrul Temel
This study proposes a new priority setting method for identifying critical information gaps in a multisector system. The method uses graph-theoretical concepts and principles of systems theory in characterizing the underlying information structure of the system. Its application is illustrated in the context of malaria control in Tanzania, drawing on the findings of a workshop held in October 2003 ...... hiện toàn bộ
Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China
The European Journal of Health Economics - Tập 24 - Trang 197-207 - 2022
Guizhi Weng, Yanming Hong, Nan Luo, Clara Mukuria, Jie Jiang, Zhihao Yang, Sha Li
EQ-5D-3L has been used in the National Health Services Survey of China since 2008 to monitor population health. The five-level version of EQ-5D was developed, but there lacks evidence to support the use of five-level version of EQ-5D in China. This study was conducted to compare the measurement properties of both the EQ-5D-3L and EQ-5D-5L in quantifying health-related quality of life (HRQoL) burde...... hiện toàn bộ
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review
The European Journal of Health Economics - Tập 24 - Trang 1151-1216 - 2022
Michela Meregaglia, Elena Nicod, Michael Drummond
Rare diseases negatively impact patients’ quality of life, but the estimation of health state utility values (HSUVs) in research studies and cost–utility models for health technology assessment is challenging. This study compared the methods for estimating the HSUVs included in manufacturers’ submissions of orphan drugs to the National Institute for Health and Care Excellence (NICE) with those of ...... hiện toàn bộ
Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
The European Journal of Health Economics - Tập 20 Số 3 - Trang 407-417 - 2019
Najmiatul Fitria, Thea van Asselt, Maarten J. Postma
Redistributional consequences of early childhood intervention
The European Journal of Health Economics - Tập 14 Số 3 - Trang 373-381 - 2013
Tim Lohse, Peter F. Lutz, Christian Thomann
Health-related quality of life in elderly people with hypertension and the estimation of minimally important difference using EQ-5D-5L in Hong Kong SAR, China
The European Journal of Health Economics - Tập 21 Số 6 - Trang 869-879 - 2020
Eliza Lai Yi Wong, Richard Huan Xu, Annie L.M. Cheung
Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France
The European Journal of Health Economics - Tập 15 - Trang 661-673 - 2013
Hassan Serrier, Hélène Sultan-Taieb, Danièle Luce, Sophie Bejean
The objective of this article was to estimate the social cost of respiratory cancer cases attributable to occupational risk factors in France in 2010. According to the attributable fraction method and based on available epidemiological data from the literature, we estimated the number of respiratory cancer cases due to each identified risk factor. We used the cost-of-illness method with a prevalen...... hiện toàn bộ
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD)
The European Journal of Health Economics - - 2024
Louis S. Matza, Katie D. Stewart, Marie Fournier, Donna Rowen, Robin Lachmann, Maurizio Scarpa, Eugen Mengel, Travis Obermeyer, Evren Ayik, Fernando Laredo, Ruth Pulikottil-Jacob
Acid sphingomyelinase deficiency (ASMD) type B is a rare genetic disorder leading to enlargement of the spleen and liver, pulmonary dysfunction, and other symptoms. Cost-utility analyses are often conducted to quantify the value of new treatments, and these analyses require health state utilities. Therefore, the purpose of this study was to estimate utilities associated with varying levels of seve...... hiện toàn bộ
Pharmaceutical policy in Italy
The European Journal of Health Economics - - 2006
Livio Garattini, Dante Cornago
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
The European Journal of Health Economics - Tập 19 Số 8 - Trang 1163-1172 - 2018
Meng, Yang, Hertel, Nadine, Ellis, John, Morais, Edith, Johnson, Helen, Philips, Zoe, Roskell, Neil, Walker, Andrew, Lee, Dawn
Nivolumab was the first programmed death receptor 1 (PD-1) immune checkpoint inhibitor to demonstrate long-term survival benefit in a clinical trial setting for advanced melanoma patients. To evaluate the cost effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England. A Markov state-transition model was developed to estimate the lifetime costs and benefits o...... hiện toàn bộ
Tổng số: 1,328   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10